Global regulatory reach DLRC operates across the UK, Germany, and the US, serving life science developers from startups to top five pharma. This global footprint suggests sales opportunities with multinational programs needing coordinated regulatory, HTA, and market access support across regions.

Integrated regulatory value Offerings span regulatory affairs, HTA, and market access with lifecycle management. Potential upsell to clients needing end-to-end support from non-clinical through post-approval, emphasizing faster market access and payer engagement.

Quality and sustainability Recognized for regulatory excellence and certified B Corporation with science-based targets and carbon monitoring. Prospect clients prioritizing ESG-aligned suppliers may prefer DLRC for governance, social responsibility, and environmental credentials.

Industry credibility Awards and accreditations such as Queen’s/King’s Awards, TOPRA, ISO 9001, Investors in People Silver reinforce trust with potential clients and partners in regulatory, HTA, and life sciences sectors.

Growth signals Recent leadership expansion in the US and notable project awards indicate momentum. This suggests opportunities to target mid‑to‑large life science companies pursuing US market access and cross‑border regulatory strategies.